PMNL (5 × 106) suspended in PBS pH 7.4 with 1 mg/mL
glucose or freshly withdrawn human whole blood were preincubated with
the test compounds for 10 min (or as indicated) at 37 °C. 5-LOX
product formation in PMNL was triggered by addition of arachidonic
acid (20 μM) and/or Ca2+-ionophore A23187 (2.5 μM;
Sigma-Aldrich) followed by incubation for 10 min at 37 °C. The
reaction was stopped with an equal volume of methanol.
Blood
was treated with Ca2+-ionophore A23187 (30 μM) for
10 min at 37 °C or was first primed for 30 min with LPS (1 μg/mL)
and then stimulated with fMLP (1 μM; Sigma-Aldrich) for 15 min.
After the reaction was stopped on ice, plasma was prepared (600g, 10 min, 4 °C), and aliquots were mixed with an equal
volume of methanol. Proteins were precipitated at −20 °C
for 2 h and removed by centrifugation (600g, 15 min,
4 °C).
Major 5-LOX metabolites (all-trans isomers of LTB4 and
5-HETE) and, for PMNL, additionally 12-HETE (major 12-LOX product)
and 15-HETE (major 15-LOX product) were extracted and analyzed by
RP-HPLC as described for the determination of cell-free 5-LOX activity.
Zileuton (3 μM) was used as the reference 5-LOX inhibitor.